Similarly, patients with SKCM who had high levels of TGFB1 had longer survival rates (P=0.008), while high TGFB1 in patients with LAML, LGG, MESO, and STAD was associated with poor OS (P=0.003, P=0.03, P< 0.001, and P=0.027 respectively). The gene discussed is TGFB1; the disease is gastric adenocarcinoma.